Literature DB >> 8191628

Assessment of anthracycline cardiomyopathy by endomyocardial biopsy.

B Mackay1, M S Ewer, C H Carrasco, R S Benjamin.   

Abstract

Ultrastructural evaluation of endomyocardial biopsy specimens is a sensitive and effective method with which to detect and quantitate cardiotoxicity produced by anthracylines. The procedure and grading system used at the M.D. Anderson Cancer Center are described, and some of the pitfalls that may be encountered by the electron microscopist are reviewed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8191628     DOI： 10.3109/01913129409016291

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN： 0191-3123            Impact factor:   1.094


  23 in total

Review 1.  Early detection of chemotherapy-related left ventricular dysfunction.

Authors:  Jeanne M DeCara
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 2.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?

Authors:  Douglas B Sawyer; Xuyang Peng; Billy Chen; Laura Pentassuglia; Chee Chew Lim
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

3.  Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction?

Authors:  Ronald G Schwartz; Nicholas Venci
Journal:  J Nucl Cardiol       Date:  2015-07-24       Impact factor: 5.952

Review 4.  Cardiotoxicity of anticancer treatments: what the cardiologist needs to know.

Authors:  Michael S Ewer; Steven M Ewer
Journal:  Nat Rev Cardiol       Date:  2010-10       Impact factor: 32.419

5.  Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study.

Authors:  Sandra M Swain; Michael S Ewer; Javier Cortés; Dino Amadori; David Miles; Adam Knott; Emma Clark; Mark C Benyunes; Graham Ross; José Baselga
Journal:  Oncologist       Date:  2013-03-08

Review 6.  New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.

Authors:  Iain Rj Macpherson; Tr Jeffry Evans
Journal:  Breast Cancer (Dove Med Press)       Date:  2009-08-31

Review 7.  Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.

Authors:  Michel G Khouri; Pamela S Douglas; John R Mackey; Miguel Martin; Jessica M Scott; Marielle Scherrer-Crosbie; Lee W Jones
Journal:  Circulation       Date:  2012-12-04       Impact factor: 29.690

Review 8.  Chemotherapy-induced cardiomyopathy.

Authors:  Angela Y Higgins; Thomas D O'Halloran; James D Chang
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

Review 9.  Emerging paradigms in cardiomyopathies associated with cancer therapies.

Authors:  Bonnie Ky; Pimprapa Vejpongsa; Edward T H Yeh; Thomas Force; Javid J Moslehi
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 10.  Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.

Authors:  Atiar M Rahman; Syed Wamique Yusuf; Michael S Ewer
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.